NewsBabel NewsBabel

Global headlines in real time

← Back to Direct feed

IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

Tmt Newswire Imunon Makes The Frontline Case For Phase 3 Imnn-001 Study: 14.7-Month Os Signal Historical Il-12 Safety Barriers Overcome Enrolling Ahead
The Manila Times English
24 Sep 2026, 12:11 GMT By GlobeNewswire
Download metadata bundle
The Manila Times logo
Article IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
Credit: GlobeNewswire

2026 R&D Day presentation highlights include:

Download Article Open Original Source